Different STAT transcription complexes drive early and delayed responses to type i IFNs

Journal of Immunology

Volumn 195, Issue 1, 2015, Pages 210-216

  Abdul Sater, Ali A ^a,d   Majoros, Andrea ^b   Plumlee, Courtney R ^a,e   Perry, Stuart ^c   Gu, Ai Di ^a   Lee, Carolyn ^a   Shresta, Sujan ^c   Decker, Thomas ^b   Schindler, Christian ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; INTERFERON; INTERFERON REGULATORY FACTOR 9; STAT1 PROTEIN; STAT2 PROTEIN; ALPHA BETA INTERFERON RECEPTOR; IFNAR1 PROTEIN, MOUSE; IRF9 PROTEIN, MOUSE; STAT1 PROTEIN, MOUSE; STAT2 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BONE MARROW DERIVED MACROPHAGE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE RESPONSE; GENE EXPRESSION; IN VIVO STUDY; INNATE IMMUNITY; LEGIONELLA PNEUMOPHILA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; BONE MARROW CELL; C57BL MOUSE; DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; KNOCKOUT MOUSE; LEGIONNAIRE DISEASE; MACROPHAGE; MICROBIOLOGY; PATHOLOGY; PRIMARY CELL CULTURE; PROTEIN MULTIMERIZATION; TIME;

ANIMALS; BONE MARROW CELLS; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; INTERFERON-GAMMA; INTERFERON-STIMULATED GENE FACTOR 3, GAMMA SUBUNIT; LEGIONELLA PNEUMOPHILA; LEGIONELLOSIS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PRIMARY CELL CULTURE; PROTEIN MULTIMERIZATION; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; TIME FACTORS;

EID: 84932177973     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401139     Document Type: Article

References (45)

1. Mykietiuk, A., J. Carratalà, N. Fernández-Sabé, J. Dorca, R. Verdaguer, F. Manresa, and F. Gudiol. 2005. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Clin. Infect. Dis. 40: 794-799.
2. Richards, A. M., J. E. Von Dwingelo, C. T. Price, and Y. Abu Kwaik. 2013. Cellular microbiology and molecular ecology of Legionella-amoeba interaction. Virulence 4: 307-314.
3. Vance, R. E. 2010. Immunology taught by bacteria. J. Clin. Immunol. 30: 507-511.
4. Segal, G., M. Feldman, and T. Zusman. 2005. The Icm/Dot type-IV secretion systems of Legionella pneumophila and Coxiella burnetii. FEMS Microbiol. Rev. 29: 65-81.
5. Schindler, C., D. E. Levy, and T. Decker. 2007. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282: 20059-20063.
6. Rusinova, I., S. Forster, S. Yu, A. Kannan, M. Masse, H. Cumming, R. Chapman, and P. J. Hertzog. 2013. Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res. 41: D1040-D1046.
7. Schoggins, J. W., S. J. Wilson, M. Panis, M. Y. Murphy, C. T. Jones, P. Bieniasz, and C. M. Rice. 2011. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472: 481-485.
8. MacMicking, J. D. 2012. Interferon-inducible effector mechanisms in cellautonomous immunity. Nat. Rev. Immunol. 12: 367-382.
9. Chowdhury, F. Z., and J. D. Farrar. 2013. STAT2: A shape-shifting anti-viral super STAT. JAK-STAT 2: e23633.
10. Karaghiosoff, M., H. Neubauer, C. Lassnig, P. Kovarik, H. Schindler, H. Pircher, B. McCoy, C. Bogdan, T. Decker, G. Brem, et al. 2000. Partial impairment of cytokine responses in Tyk2-deficient mice. Immunity 13: 549-560.
11. Park, C., S. Li, E. Cha, and C. Schindler. 2000. Immune response in Stat2 knockout mice. Immunity 13: 795-804.
12. Zhao, W., E. N. Cha, C. Lee, C. Y. Park, and C. Schindler. 2007. Stat2-dependent regulation of MHC class II expression. J. Immunol. 179: 463-471.
13. Yoshimura, A. 2009. Regulation of cytokine signaling by the SOCS and Spred family proteins. Keio J. Med. 58: 73-83.
14. Gough, D. J., N. L. Messina, C. J. Clarke, R. W. Johnstone, and D. E. Levy. 2012. Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36: 166-174.
15. Zaidi, M. R., and G. Merlino. 2011. The two faces of interferon-g in cancer. Clin. Cancer Res. 17: 6118-6124.
16. Akamine, M., F. Higa, S. Haranaga, M. Tateyama, N. Mori, K. Heuner, and J. Fujita. 2007. Interferon-gamma reverses the evasion of Birc1e/Naip5 gene mediated murine macrophage immunity by Legionella pneumophila mutant lacking flagellin. Microbiol. Immunol. 51: 279-287.
17. Plumlee, C. R., C. Lee, A. A. Beg, T. Decker, H. A. Shuman, and C. Schindler. 2009. Interferons direct an effective innate response to Legionella pneumophila infection. J. Biol. Chem. 284: 30058-30066.
18. Coers, J., R. E. Vance, M. F. Fontana, and W. F. Dietrich. 2007. Restriction of Legionella pneumophila growth in macrophages requires the concerted action of cytokine and Naip5/Ipaf signalling pathways. Cell. Microbiol. 9: 2344-2357.
19. Perry, S. T., M. D. Buck, S. M. Lada, C. Schindler, and S. Shresta. 2011. STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. PLoS Pathog. 7: e1001297.
20. Hahm, B., M. J. Trifilo, E. I. Zuniga, and M. B. Oldstone. 2005. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 22: 247-257.
21. Bluyssen, H. A., and D. E. Levy. 1997. Stat2 is a transcriptional activator that requires sequence-specific contacts provided by stat1 and p48 for stable interaction with DNA. J. Biol. Chem. 272: 4600-4605.
22. Lou, Y. J., X. R. Pan, P. M. Jia, D. Li, S. Xiao, Z. L. Zhang, S. J. Chen, Z. Chen, and J. H. Tong. 2009. IRF-9/STAT2 [corrected] functional interaction drives retinoic acid-induced gene G expression independently of STAT1. Cancer Res. 69: 3673-3680.
23. Sarkis, P. T., S. Ying, R. Xu, and X. F. Yu. 2006. STAT1-independent cell typespecific regulation of antiviral APOBEC3G by IFN-alpha. J. Immunol. 177: 4530-4540.
24. George, C. X., S. Das, and C. E. Samuel. 2008. Organization of the mouse RNAspecific adenosine deaminase Adar1 gene 59-region and demonstration of STAT1-independent, STAT2-dependent transcriptional activation by interferon. Virology 380: 338-343.
25. Fink, K., L. Martin, E. Mukawera, S. Chartier, X. De Deken, E. Brochiero, F. Miot, and N. Grandvaux. 2013. IFNb/TNFa synergism induces a noncanonical STAT2/IRF9-dependent pathway triggering a novel DUOX2 NADPH oxidase-mediated airway antiviral response. Cell Res. 23: 673-690.
26. Zhang, S. Y., S. Boisson-Dupuis, A. Chapgier, K. Yang, J. Bustamante, A. Puel, C. Picard, L. Abel, E. Jouanguy, and J. L. Casanova. 2008. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Immunol. Rev. 226: 29-40.
27. Ramachandran, A., and C. M. Horvath. 2009. Paramyxovirus disruption of interferon signal transduction: STATus report. J. Interferon Cytokine Res. 29: 531-537.
28. Versteeg, G. A., and A. García-Sastre. 2010. Viral tricks to grid-lock the type I interferon system. Curr. Opin. Microbiol. 13: 508-516.
29. Meraz, M. A., J. M. White, K. C. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, et al. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84: 431-442.
30. Wang, J., N. Pham-Mitchell, C. Schindler, and I. L. Campbell. 2003. Dysregulated Sonic hedgehog signaling and medulloblastoma consequent to IFN-alphastimulated STAT2-independent production of IFN-gamma in the brain. J. Clin. Invest. 112: 535-543.
31. Kimura, T., Y. Kadokawa, H. Harada, M. Matsumoto, M. Sato, Y. Kashiwazaki, M. Tarutani, R. S. Tan, T. Takasugi, and T. Matsuyama, et al. 1996. Essential and non-redundant roles of p48 (ISGF3 gamma) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells 1: 115-124.
32. Song, L., S. Bhattacharya, A. A. Yunus, C. D. Lima, and C. Schindler. 2006. Stat1 and SUMO modification. Blood 108: 3237-3244.
33. Blasi, E., B. J. Mathieson, L. Varesio, J. L. Cleveland, P. A. Borchert, and U. R. Rapp. 1985. Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus. Nature 318: 667-670.
34. Farlik, M., B. Reutterer, C. Schindler, F. Greten, C. Vogl, M. Müller, and T. Decker. 2010. Nonconventional initiation complex assembly by STAT and NFkappaB transcription factors regulates nitric oxide synthase expression. Immunity 33: 25-34.
35. Zhao, W., C. Lee, R. Piganis, C. Plumlee, N. de Weerd, P. J. Hertzog, and C. Schindler. 2008. A conserved IFN-alpha receptor tyrosine motif directs the biological response to type I IFNs. J. Immunol. 180: 5483-5489.
36. Rodriguez-Barrueco, R., N. Marshall, and J. M. Silva. 2013. Pooled shRNA screenings: experimental approach. Methods Mol. Biol. 980: 353-370.
37. Schindler, C., K. Shuai, V. R. Prezioso, and J. E. Darnell, Jr. 1992. Interferondependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257: 809-813.
38. Litvak, V., A. V. Ratushny, A. E. Lampano, F. Schmitz, A. C. Huang, A. Raman, A. G. Rust, A. Bergthaler, J. D. Aitchison, and A. Aderem. 2012. A FOXO3-IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses. Nature 490: 421-425.
39. Durbin, J. E., R. Hackenmiller, M. C. Simon, and D. E. Levy. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84: 443-450.
40. Pine, R., A. Canova, and C. Schindler. 1994. Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF-1 promoter to mediate induction by IFN alpha and IFN gamma, and is likely to autoregulate the p91 gene. EMBO J. 13: 158-167.
41. Schindler, C., X. Y. Fu, T. Improta, R. Aebersold, and J. E. Darnell, Jr. 1992. Proteins of transcription factor ISGF-3: one gene encodes the 91-and 84-kDa ISGF-3 proteins that are activated by interferon alpha. Proc. Natl. Acad. Sci. USA 89: 7836-7839.
42. Piganis, R. A., N. A. De Weerd, J. A. Gould, C. W. Schindler, A. Mansell, S. E. Nicholson, and P. J. Hertzog. 2011. Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2. J. Biol. Chem. 286: 33811-33818.
43. Shresta, S., K. L. Sharar, D. M. Prigozhin, H. M. Snider, P. R. Beatty, and E. Harris. 2005. Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J. Immunol. 175: 3946-3954.
44. Reich, N. C., and L. Liu. 2006. Tracking STAT nuclear traffic. Nat. Rev. Immunol. 6: 602-612.
45. Böhmer, F. D., and K. Friedrich. 2014. Protein tyrosine phosphatases as wardens of STAT signaling. JAK-STAT 3:e28087.